Clinical Approach to Tingling / Paresthesia
Comprehensive Practical Framework1. Symptom Overview
Understanding the clinical significance and classification of tingling and paresthesia
Paresthesia is one of the most common neurological complaints encountered in clinical practice, accounting for approximately 5-8% of all neurology outpatient visits and representing a significant proportion of primary care consultations. Population studies suggest that up to 8% of adults experience chronic paresthesias, with prevalence increasing substantially with age. The symptom often generates considerable patient anxiety due to concerns about serious neurological disease, yet in the majority of cases, the underlying cause is benign and treatable.
Definition
Paresthesia refers to abnormal sensations that occur without an apparent stimulus. These sensations are typically described as tingling, pins and needles, prickling, buzzing, or numbness. Paresthesias arise from dysfunction anywhere along the sensory pathway — from peripheral receptors to the sensory cortex. The term is distinct from dysesthesia, which describes unpleasant or painful abnormal sensations, and anesthesia, which refers to complete loss of sensation.
Key Epidemiology
- Carpal tunnel syndrome: Affects 3-6% of the general population; most common entrapment neuropathy
- Diabetic peripheral neuropathy: Present in approximately 50% of patients with longstanding diabetes
- Idiopathic peripheral neuropathy: Accounts for 25-30% of all neuropathy cases
- Multiple sclerosis: Sensory symptoms are the presenting feature in approximately 45% of patients
Classification by Duration
| Category | Duration | Common Causes | Clinical Significance |
|---|---|---|---|
| Acute | Less than 4 weeks | Nerve compression, hyperventilation, transient ischemic attack, acute inflammatory demyelinating polyneuropathy | Requires urgent evaluation if associated with weakness or rapid progression; may indicate stroke or Guillain-Barré syndrome |
| Subacute | 4 weeks to 3 months | Vitamin deficiencies (B12), early diabetic neuropathy, medication-induced neuropathy, early multiple sclerosis | Suggests metabolic, nutritional, or early demyelinating process; reversible if identified early |
| Chronic | Greater than 3 months | Chronic idiopathic axonal polyneuropathy, diabetic neuropathy, hereditary neuropathies, chronic inflammatory demyelinating polyneuropathy | Often indicates established neuropathy; focus shifts to identifying treatable causes and symptom management |
Classification by Character and Quality
Positive Sensory Symptoms
Tingling (pins and needles): The most common description; suggests irritation or spontaneous firing of sensory nerve fibers
Burning: Often indicates small fiber involvement; common in diabetic neuropathy and small fiber neuropathy
Electric shock sensations: Suggests nerve root or dorsal column involvement; characteristic of Lhermitte’s sign in cervical myelopathy
Crawling or formication: Sensation of insects crawling; may suggest psychiatric causes or drug effects
Negative Sensory Symptoms
Numbness: Indicates loss of sensory function; implies significant sensory fiber dysfunction
Dead or wooden feeling: Suggests more advanced sensory loss; often accompanied by objective sensory deficit on examination
Loss of proprioception: Results in sensory ataxia; indicates large fiber or dorsal column involvement
Loss of temperature sensation: Indicates spinothalamic tract or small fiber involvement
Classification by Distribution Pattern
| Pattern | Description | Suggests |
|---|---|---|
| Length-dependent (stocking-glove) | Begins distally in feet and hands, progresses proximally symmetrically | Peripheral polyneuropathy (diabetic, toxic, metabolic, hereditary) |
| Dermatomal | Follows a specific nerve root distribution | Radiculopathy (disc herniation, foraminal stenosis, herpes zoster) |
| Single nerve territory | Confined to distribution of one peripheral nerve | Mononeuropathy (entrapment, compression, trauma) |
| Multiple discrete nerves | Affects multiple individual nerves asymmetrically | Mononeuritis multiplex (vasculitis, diabetes, sarcoidosis) |
| Hemisensory | Involves one side of body including face | Central lesion (thalamic stroke, cortical lesion, multiple sclerosis) |
| Sensory level | Sensory changes below a specific spinal level | Spinal cord pathology (myelopathy, transverse myelitis, spinal cord compression) |
| Non-anatomical | Does not follow any recognized neurological pattern | Functional neurological disorder, hyperventilation syndrome, anxiety |
Classification by Temporal Pattern
| Pattern | Description | Suggests |
|---|---|---|
| Constant | Present continuously without significant fluctuation | Established neuropathy, structural lesion, chronic compression |
| Intermittent | Comes and goes with symptom-free intervals | Entrapment neuropathy (worse with provocative positions), vascular claudication, migraine aura |
| Progressive | Steadily worsening over time | Progressive neuropathy, expanding structural lesion, metabolic cause |
| Relapsing-remitting | Episodes of symptoms followed by complete or partial recovery | Multiple sclerosis, chronic inflammatory demyelinating polyneuropathy |
| Positional | Triggered or worsened by specific body positions | Nerve entrapment, thoracic outlet syndrome, cervical radiculopathy |
Key Concept: The Anatomical Approach
The distribution pattern of paresthesia is the single most important clinical clue to localization. Ask yourself: Does this pattern suggest a peripheral nerve, nerve root, plexus, spinal cord, or brain lesion? The answer will guide your entire diagnostic approach.
- Peripheral neuropathy: Symmetric, length-dependent, distal predominant
- Radiculopathy: Dermatomal, often with neck or back pain
- Myelopathy: Sensory level, bilateral symptoms below lesion
- Central lesion: Hemisensory, face involved, associated cortical signs
2. Pathophysiology and Mechanisms
Understanding the underlying mechanisms of tingling and paresthesia
Paresthesias arise from abnormal generation or transmission of sensory signals anywhere along the somatosensory pathway. Understanding these mechanisms is crucial for accurate diagnosis and targeted treatment. The sensory pathway begins at peripheral receptors, travels through peripheral nerves, enters the spinal cord via dorsal root ganglia, ascends through specific tracts, and terminates in the somatosensory cortex. Dysfunction at any level can produce paresthesia, but the character and distribution of symptoms often provide clues to the site of pathology.
The Somatosensory Pathway
| Component | Structure | Function | Clinical Relevance |
|---|---|---|---|
| Peripheral Receptors | Specialized nerve endings in skin, muscle, joints | Transduce mechanical, thermal, and chemical stimuli into electrical signals | Receptor damage causes loss of specific sensory modalities |
| Peripheral Nerve Fibers | Aβ (large myelinated), Aδ (small myelinated), C (unmyelinated) fibers | Conduct sensory information to spinal cord at different velocities | Selective fiber damage produces characteristic sensory loss patterns |
| Dorsal Root Ganglion | Cell bodies of primary sensory neurons | Houses the cell body; vulnerable to metabolic and inflammatory injury | Ganglionopathies cause non-length-dependent sensory loss |
| Dorsal Horn | Posterior spinal cord gray matter | First synapse for pain and temperature; modulation of sensory input | Central sensitization may perpetuate chronic pain and paresthesia |
| Ascending Tracts | Dorsal columns (proprioception, vibration), spinothalamic tract (pain, temperature) | Carry specific sensory modalities to brainstem and thalamus | Tract-specific lesions produce dissociated sensory loss |
| Thalamus | Ventral posterolateral and ventral posteromedial nuclei | Relay and process sensory information before cortical transmission | Thalamic lesions cause hemisensory symptoms and central pain |
| Somatosensory Cortex | Postcentral gyrus (primary sensory cortex) | Conscious perception and discrimination of sensory stimuli | Cortical lesions may cause sensory neglect or agnosia |
Peripheral Nerve Fiber Types and Clinical Correlates
Large Myelinated Fibers (Aβ)
Diameter: 6-12 micrometers
Conduction velocity: 35-75 meters per second
Function: Light touch, vibration sense, proprioception
Clinical significance: Damage causes numbness, loss of vibration sense, sensory ataxia, and positive Romberg sign. Preferentially affected in demyelinating neuropathies and vitamin B12 deficiency.
Small Myelinated Fibers (Aδ)
Diameter: 1-5 micrometers
Conduction velocity: 5-35 meters per second
Function: Sharp pain, cold temperature sensation
Clinical significance: Damage causes impaired pinprick and cold sensation. Affected early in some toxic and metabolic neuropathies.
Unmyelinated Fibers (C)
Diameter: 0.2-1.5 micrometers
Conduction velocity: 0.5-2 meters per second
Function: Dull pain, warm temperature, autonomic function
Clinical significance: Damage causes burning pain, heat intolerance, and autonomic dysfunction. Characteristic of small fiber neuropathy; often missed on nerve conduction studies.
Mechanisms Producing Paresthesia
| Mechanism | Pathophysiology | Clinical Examples | Characteristics |
|---|---|---|---|
| Ectopic impulse generation | Abnormal spontaneous firing of damaged or regenerating nerve fibers at sites of injury | Nerve entrapment, neuroma formation, demyelinating neuropathy | Positive symptoms (tingling, electric shocks); often provoked by percussion (Tinel’s sign) |
| Ephaptic transmission | Cross-talk between adjacent nerve fibers due to loss of myelin insulation | Demyelinating neuropathies, trigeminal neuralgia | Paroxysmal symptoms; may be triggered by light touch or movement |
| Abnormal temporal summation | Enhanced central nervous system response to repetitive peripheral stimulation | Central sensitization, chronic pain syndromes | Allodynia (pain from non-painful stimuli), hyperalgesia |
| Deafferentation | Loss of normal sensory input leads to spontaneous central nervous system activity | Phantom limb sensation, post-stroke pain | Persistent paresthesia despite complete peripheral nerve loss |
| Ion channel dysfunction | Altered expression or function of sodium, potassium, or calcium channels | Channelopathies, erythromelalgia, paroxysmal extreme pain disorder | Episodic symptoms; may respond to specific channel blockers |
| Metabolic membrane instability | Electrolyte disturbances affect nerve membrane potential and excitability | Hypocalcemia, hypomagnesemia, hypoglycemia | Perioral and acral distribution; often bilateral and symmetric |
| Ischemia | Reduced blood flow impairs nerve function; large myelinated fibers affected first | Transient ischemic attack, peripheral vascular disease, thoracic outlet syndrome | Position-dependent; associated with weakness in vascular insufficiency |
How Specific Conditions Cause Paresthesia
| Condition | Mechanism | Treatment Implication |
|---|---|---|
| Carpal tunnel syndrome | Chronic compression causes focal demyelination and axonal injury at the wrist; ectopic impulse generation produces spontaneous tingling | Decompression surgery reverses demyelination if performed before significant axonal loss occurs |
| Diabetic peripheral neuropathy | Hyperglycemia causes metabolic injury to nerve fibers through polyol pathway activation, oxidative stress, and microvascular damage; small fibers affected early | Glycemic control may slow progression; symptomatic treatment targets central sensitization and ion channel dysfunction |
| Vitamin B12 deficiency | Impaired myelin synthesis affects large myelinated fibers and dorsal columns; results in subacute combined degeneration of the spinal cord | B12 replacement can halt progression and partially reverse symptoms if treated early |
| Multiple sclerosis | Autoimmune demyelination in central nervous system white matter disrupts sensory pathways; inflammation causes positive symptoms, demyelination causes negative symptoms | Disease-modifying therapies reduce relapse frequency; acute symptoms may respond to corticosteroids |
| Cervical radiculopathy | Nerve root compression by disc herniation or osteophyte causes focal ischemia and mechanical injury; dermatomal distribution reflects specific root involvement | Surgical decompression indicated for progressive weakness or intractable pain; most cases resolve with conservative management |
| Guillain-Barré syndrome | Autoimmune attack on peripheral nerve myelin or axons following infection; acute inflammatory demyelination causes conduction block and paresthesia | Intravenous immunoglobulin or plasmapheresis can shorten disease course; supportive care critical |
| Hyperventilation syndrome | Respiratory alkalosis reduces ionized calcium, increasing nerve membrane excitability and causing perioral and acral paresthesias | Reassurance and breathing retraining; symptoms resolve rapidly with normalization of carbon dioxide levels |
| Small fiber neuropathy | Selective damage to small myelinated and unmyelinated fibers; often idiopathic or associated with diabetes, amyloidosis, or autoimmune conditions | Treatment targets underlying cause when identified; symptomatic management for neuropathic pain |
Central Versus Peripheral Mechanisms
Peripheral Mechanisms
- Axonal injury: Wallerian degeneration causes sensory loss; regeneration may produce paresthesia
- Demyelination: Slowed conduction, conduction block, and ectopic impulse generation
- Ganglionopathy: Cell body damage causes non-length-dependent sensory loss
- Channelopathy: Altered ion channel function causes hyperexcitability
Central Mechanisms
- Demyelination: Multiple sclerosis plaques in sensory pathways cause positive and negative symptoms
- Ischemia: Stroke affecting thalamus or sensory cortex causes hemisensory symptoms
- Central sensitization: Enhanced excitability of central neurons perpetuates chronic pain
- Deafferentation: Loss of input leads to spontaneous central activity
Often Overlooked: Small Fiber Neuropathy
Small fiber neuropathy is frequently missed because nerve conduction studies, which assess large myelinated fibers, are normal. Patients present with burning pain, tingling, and autonomic symptoms but have preserved reflexes and normal vibration sense. Consider this diagnosis when symptoms are characteristic but standard electrodiagnostic testing is unrevealing. Skin biopsy with intraepidermal nerve fiber density measurement is the gold standard diagnostic test.
Sensory Modality and Fiber Type Correlation
| Sensory Modality | Fiber Type | Spinal Tract | Conditions Affecting This Modality |
|---|---|---|---|
| Light touch | Aβ (large myelinated) | Dorsal columns | Large fiber neuropathy, B12 deficiency, dorsal column lesions |
| Vibration | Aβ (large myelinated) | Dorsal columns | Demyelinating neuropathies, B12 deficiency, tabes dorsalis |
| Proprioception | Aβ (large myelinated) | Dorsal columns | Sensory ganglionopathy, B12 deficiency, Friedreich ataxia |
| Sharp pain (pinprick) | Aδ (small myelinated) | Spinothalamic tract | Small fiber neuropathy, syringomyelia, spinothalamic tract lesions |
| Temperature | Aδ (cold), C (warm) | Spinothalamic tract | Small fiber neuropathy, syringomyelia, lateral medullary syndrome |
| Dull pain (aching) | C (unmyelinated) | Spinothalamic tract | Small fiber neuropathy, diabetic neuropathy |
3. History Taking
A comprehensive approach to eliciting the paresthesia history
Red Flags — Require Urgent Evaluation
- Acute onset with weakness — Guillain-Barré syndrome, stroke, spinal cord compression
- Rapidly ascending symptoms — Guillain-Barré syndrome (can progress to respiratory failure)
- Bilateral sensory level on trunk — Spinal cord compression or myelitis (neurosurgical emergency)
- Bowel or bladder dysfunction — Cauda equina syndrome, spinal cord lesion
- Sudden hemisensory loss — Stroke (thalamic or cortical)
- Associated with severe headache — Stroke, central nervous system infection
- Fever with neurological symptoms — Meningitis, encephalitis, epidural abscess
- History of malignancy with new symptoms — Metastatic spinal cord compression, paraneoplastic syndrome
Systematic History: The “TINGLE” Approach
Use the mnemonic “TINGLE” to ensure comprehensive history taking for paresthesia:
- T — Timing and Tempo: When did it start? Sudden or gradual? Constant or intermittent? Progressing or stable?
- I — Investigate the Distribution: Where exactly do you feel it? Does it follow a specific pattern? One side or both?
- N — Nature and Character: What does it feel like? Pins and needles, burning, numbness, electric shocks?
- G — Generating Factors: What triggers or worsens it? Position, activity, time of day? What relieves it?
- L — Linked Symptoms: Any weakness, pain, gait problems, bowel/bladder changes, visual symptoms?
- E — Exposures and Background: Medications, alcohol, diabetes, vitamin deficiencies, family history, occupation?
Targeted Questions by Suspected Cause
| Suspected Cause | Key Features | Ask This Question |
|---|---|---|
| Carpal tunnel syndrome | Nocturnal symptoms, waking from sleep, thumb-index-middle finger distribution | “Do you wake at night with tingling in your hand? Do you shake your hand to relieve it?” |
| Cervical radiculopathy | Neck pain radiating to arm, dermatomal pattern, worse with neck movement | “Does the tingling travel from your neck down your arm? Does turning your head change the symptoms?” |
| Diabetic peripheral neuropathy | Symmetric stocking distribution, burning pain, known diabetes | “Did the symptoms start in your feet and gradually move up? Do you have diabetes or prediabetes?” |
| Multiple sclerosis | Young adult, relapsing symptoms, visual or motor symptoms, Lhermitte’s sign | “Have you had episodes of symptoms that came and went? Any vision problems or weakness in the past?” |
| Vitamin B12 deficiency | Symmetric paresthesias, gait unsteadiness, cognitive changes, dietary restrictions | “Do you follow a vegetarian or vegan diet? Have you noticed problems with balance or memory?” |
| Guillain-Barré syndrome | Recent infection, rapidly ascending weakness, areflexia | “Did you have a stomach bug or respiratory infection in the past few weeks? Is the weakness getting worse each day?” |
| Thoracic outlet syndrome | Arm symptoms with overhead activities, ulnar distribution, young adult | “Do symptoms come on when you raise your arms overhead or carry heavy bags?” |
| Peripheral vascular disease | Claudication, cold feet, risk factors for atherosclerosis | “Do your legs feel numb or tingly when walking, and does it improve with rest?” |
| Hyperventilation syndrome | Perioral and bilateral hand tingling, anxiety, lightheadedness | “Does the tingling happen when you’re anxious? Do you also feel dizzy and short of breath?” |
| Small fiber neuropathy | Burning feet, autonomic symptoms, normal strength and reflexes | “Do your feet burn, especially at night? Do you have problems with sweating, digestion, or lightheadedness on standing?” |
Lhermitte’s Sign
Ask specifically: “When you bend your neck forward, do you get an electric shock sensation down your spine or into your arms and legs?”
A positive response (Lhermitte’s sign) suggests cervical spinal cord pathology, most commonly multiple sclerosis, but also cervical spondylotic myelopathy, vitamin B12 deficiency, or radiation myelopathy.
Medication and Toxic Exposure History
Medications That Cause Paresthesia
- Chemotherapy agents: Vincristine, cisplatin, paclitaxel, oxaliplatin (often dose-limiting toxicity)
- Antimicrobials: Metronidazole, isoniazid, nitrofurantoin, fluoroquinolones
- Antiretrovirals: Didanosine, stavudine (nucleoside reverse transcriptase inhibitors)
- Cardiovascular drugs: Amiodarone, hydralazine, statins (rare)
- Anticonvulsants: Phenytoin (chronic use)
- Immunosuppressants: Tacrolimus, cyclosporine
- Others: Colchicine, disulfiram, thalidomide, excessive pyridoxine (vitamin B6)
Toxic Exposures
- Alcohol: Chronic heavy use causes axonal neuropathy; ask about quantity and duration
- Heavy metals: Lead (motor > sensory), arsenic, thallium, mercury
- Industrial solvents: N-hexane, toluene, acrylamide
- Organophosphates: Pesticide exposure
Nutritional Factors
- Deficiencies: B12, thiamine (B1), pyridoxine (B6), folate, copper, vitamin E
- Excess: Pyridoxine toxicity (more than 200 mg daily can cause sensory neuropathy)
- Bariatric surgery: Increased risk of multiple deficiencies
Relevant Past Medical and Family History
| History Element | Relevance | Conditions to Consider |
|---|---|---|
| Diabetes mellitus | Most common cause of peripheral neuropathy in developed countries | Diabetic polyneuropathy, mononeuropathy, diabetic amyotrophy |
| Thyroid disease | Hypothyroidism associated with carpal tunnel syndrome and polyneuropathy | Entrapment neuropathies, polyneuropathy |
| Autoimmune disease | Systemic lupus erythematosus, rheumatoid arthritis, Sjögren syndrome associated with neuropathy | Vasculitic neuropathy, sensory ganglionopathy, entrapment |
| Malignancy | Paraneoplastic syndromes, chemotherapy toxicity, direct invasion | Paraneoplastic sensory neuronopathy, treatment-related neuropathy |
| Renal disease | Uremic neuropathy in chronic kidney disease | Uremic polyneuropathy |
| HIV infection | Virus itself and antiretroviral medications cause neuropathy | Distal sensory polyneuropathy, antiretroviral toxic neuropathy |
| Family history of neuropathy | Suggests hereditary cause; Charcot-Marie-Tooth is most common | Hereditary sensory and motor neuropathy, familial amyloidosis |
Social and Occupational History
Occupational Considerations
Repetitive strain: Typing, assembly line work, vibrating tools — increased risk of entrapment neuropathies
Industrial exposures: Solvents, heavy metals, pesticides in manufacturing, agriculture, mining
Prolonged postures: Kneeling (peroneal neuropathy), leaning on elbows (ulnar neuropathy)
Lifestyle Factors
Alcohol consumption: Quantity, frequency, duration — threshold typically more than 100 g per day for years
Diet: Vegetarian/vegan (B12 risk), restrictive diets, eating disorders
Exercise: Excessive cycling (pudendal neuropathy), running (tarsal tunnel)
Recreational drugs: Nitrous oxide abuse causes B12 deficiency
Functional Impact Assessment
Questions to Assess Functional Impact
- “Does the numbness affect your ability to button shirts, pick up small objects, or write?”
- “Have you noticed any unsteadiness when walking, especially in the dark?”
- “Have you burned or injured yourself without realizing it?”
- “Does the tingling interfere with your sleep?”
- “Has it affected your ability to work or perform daily activities?”
Functional impairment helps gauge severity and guides urgency of investigation and treatment.
4. Physical Examination
A systematic neurological approach for patients with paresthesia
Systematic Framework: For patients presenting with paresthesia, the neurological examination is paramount. Use a structured approach: General inspection → Cranial nerves → Motor examination → Sensory examination → Reflexes → Coordination and gait → Special tests. Always examine the area of symptoms AND compare with unaffected areas.
General Inspection
- Body habitus: Obesity (increased risk of entrapment), cachexia (malignancy, malnutrition)
- Skin changes: Dry skin, hair loss, shiny skin (autonomic neuropathy); ulcers on feet (sensory loss); rashes (vasculitis, lupus)
- Muscle bulk: Wasting in specific nerve distributions (e.g., thenar eminence in carpal tunnel)
- Deformities: Pes cavus, hammer toes (hereditary neuropathy); joint deformities (Charcot joints)
- Gait observation: Watch the patient walk into the room — ataxia, foot drop, wide-based gait
- Assistive devices: Use of cane, walker (suggests significant functional impairment)
Vital Signs
| Vital Sign | What to Look For | Clinical Significance |
|---|---|---|
| Blood Pressure | Orthostatic hypotension (drop of more than 20 mmHg systolic on standing) | Autonomic neuropathy (diabetes, amyloidosis, Guillain-Barré syndrome) |
| Heart Rate | Resting tachycardia, lack of heart rate variability | Cardiac autonomic neuropathy |
| Respiratory Rate | Tachypnea, use of accessory muscles | Diaphragmatic weakness in Guillain-Barré syndrome (measure vital capacity) |
| Temperature | Fever | Infectious cause (meningitis, abscess), vasculitis |
Sensory Examination
The sensory examination is the cornerstone of evaluating paresthesia. Test systematically and compare sides. Map the distribution of abnormalities carefully — the pattern is the key to localization.
Modalities to Test
| Modality | How to Test | What It Assesses | Abnormal in |
|---|---|---|---|
| Light touch | Cotton wisp or fingertip; ask “Do you feel this?” and compare sides | Large myelinated fibers (Aβ), dorsal columns | Large fiber neuropathy, dorsal column lesions |
| Pinprick | Disposable pin; ask “Does this feel sharp?” and compare with unaffected area | Small myelinated fibers (Aδ), spinothalamic tract | Small fiber neuropathy, spinothalamic lesions |
| Temperature | Cool tuning fork or test tubes with warm and cold water | Small fibers (Aδ and C), spinothalamic tract | Small fiber neuropathy, syringomyelia |
| Vibration | 128 Hz tuning fork on bony prominences (great toe, medial malleolus, finger) | Large myelinated fibers (Aβ), dorsal columns | Large fiber neuropathy, B12 deficiency, dorsal column lesions |
| Proprioception | Hold digit by sides, move up or down; ask patient to identify direction with eyes closed | Large myelinated fibers, dorsal columns | Sensory ataxia, B12 deficiency, ganglionopathy |
Patterns to Recognize
Length-Dependent (Stocking-Glove)
Sensory loss starts distally and ascends; symmetric; suggests polyneuropathy. Document the proximal extent of sensory loss on both legs and arms.
Dermatomal
Follows a nerve root distribution; suggests radiculopathy. Know key dermatomes: C6 (thumb), C7 (middle finger), C8 (little finger), L5 (dorsum of foot), S1 (lateral foot).
Single Nerve Territory
Confined to one peripheral nerve distribution; suggests mononeuropathy. Common: median nerve (carpal tunnel), ulnar nerve, lateral femoral cutaneous nerve (meralgia paresthetica).
Sensory Level
Sensation normal above a specific spinal level and abnormal below; suggests spinal cord pathology. Document the level precisely using dermatome landmarks.
Motor Examination
Although the chief complaint is sensory, motor examination is essential — many conditions causing paresthesia also affect motor function, and weakness indicates more significant pathology.
| Component | What to Assess | Clinical Significance |
|---|---|---|
| Muscle bulk | Compare muscle groups side to side; look for focal wasting | Thenar wasting (carpal tunnel), intrinsic hand wasting (ulnar neuropathy, C8-T1 radiculopathy), distal leg wasting (polyneuropathy) |
| Tone | Passive movement of limbs; assess for spasticity or flaccidity | Increased tone suggests upper motor neuron lesion (myelopathy); decreased tone in lower motor neuron or acute upper motor neuron lesions |
| Power | Test key muscle groups using Medical Research Council scale (0-5) | Pattern of weakness helps localize: myotomal (radiculopathy), single nerve (mononeuropathy), distal (polyneuropathy), pyramidal (upper motor neuron) |
| Fasciculations | Observe for spontaneous muscle twitching | Lower motor neuron pathology; concerning if widespread with weakness |
Key Muscles to Test by Root Level
Upper Limb:
- C5: Deltoid, biceps
- C6: Wrist extensors, brachioradialis
- C7: Triceps, wrist flexors, finger extensors
- C8: Finger flexors, intrinsic hand muscles
- T1: Intrinsic hand muscles (finger abduction)
Lower Limb:
- L2: Hip flexors
- L3: Knee extensors (quadriceps)
- L4: Ankle dorsiflexors
- L5: Great toe extensor, hip abductors
- S1: Ankle plantarflexors, hip extensors
Deep Tendon Reflexes
| Reflex | Root Level | Decreased (Hyporeflexia) | Increased (Hyperreflexia) |
|---|---|---|---|
| Biceps | C5-C6 | C5-C6 radiculopathy, peripheral neuropathy | Upper motor neuron lesion above C5 |
| Brachioradialis | C5-C6 | C5-C6 radiculopathy | Upper motor neuron lesion above C5 |
| Triceps | C7-C8 | C7 radiculopathy | Upper motor neuron lesion above C7 |
| Knee (patellar) | L3-L4 | L3-L4 radiculopathy, femoral neuropathy, polyneuropathy | Upper motor neuron lesion above L3 |
| Ankle (Achilles) | S1-S2 | S1 radiculopathy, polyneuropathy (often lost early) | Upper motor neuron lesion above S1 |
Reflex Pattern Recognition:
- Globally decreased or absent: Peripheral neuropathy, Guillain-Barré syndrome
- Decreased at one level, increased below: Radiculopathy with myelopathy
- Globally increased with upgoing plantars: Upper motor neuron lesion (myelopathy, central lesion)
- Normal reflexes with sensory symptoms: Small fiber neuropathy, early large fiber neuropathy
Coordination and Gait
Coordination Tests
- Finger-nose-finger: Cerebellar ataxia versus sensory ataxia
- Heel-shin test: Assess lower limb coordination
- Rapid alternating movements: Dysdiadochokinesia suggests cerebellar pathology
Gait Assessment
- Romberg test: Positive (increased sway with eyes closed) indicates proprioceptive loss
- Tandem gait: Heel-to-toe walking; sensitive for subtle ataxia
- Heel and toe walking: Tests L4-L5 (dorsiflexion) and S1 (plantarflexion)
- Watch for: Steppage gait (foot drop), wide-based gait (sensory ataxia), spastic gait (myelopathy)
Special Tests and Provocative Maneuvers
| Test | How to Perform | Positive Finding | Suggests |
|---|---|---|---|
| Tinel’s sign | Tap over the nerve at site of suspected entrapment | Tingling in nerve distribution | Nerve entrapment at that site (carpal tunnel, cubital tunnel) |
| Phalen’s test | Hold wrists in full flexion for 60 seconds | Paresthesias in median nerve distribution | Carpal tunnel syndrome |
| Reverse Phalen’s test | Hold wrists in full extension for 60 seconds | Paresthesias in median nerve distribution | Carpal tunnel syndrome |
| Spurling’s test | Extend and rotate neck toward affected side, apply axial compression | Reproduction of radicular symptoms | Cervical radiculopathy |
| Straight leg raise | Raise extended leg with patient supine | Radicular pain at less than 60 degrees | L4-S1 radiculopathy (usually disc herniation) |
| Lhermitte’s sign | Flex the neck forward | Electric shock sensation down spine or limbs | Cervical spinal cord pathology (multiple sclerosis, myelopathy) |
| Adson’s test | Abduct arm, extend neck, rotate head to affected side; palpate radial pulse | Diminished pulse with symptom reproduction | Thoracic outlet syndrome (low sensitivity) |
Expected Findings by Etiology
| Condition | Sensory Findings | Motor Findings | Reflexes | Other |
|---|---|---|---|---|
| Diabetic polyneuropathy | Stocking-glove loss; vibration and pinprick affected | Mild distal weakness late | Ankle jerks absent or reduced | Dry skin, foot ulcers, Charcot joints |
| Carpal tunnel syndrome | Median nerve territory (thumb, index, middle finger, radial half of ring finger) | Thenar weakness and wasting (late) | Normal | Positive Tinel’s and Phalen’s tests |
| Cervical radiculopathy | Dermatomal distribution in arm | Myotomal weakness | Reduced at affected level | Positive Spurling’s test; neck pain |
| Multiple sclerosis | Variable; may be hemisensory or patchy | Upper motor neuron pattern weakness | Hyperreflexia, upgoing plantars | Optic disc pallor, internuclear ophthalmoplegia, Lhermitte’s sign |
| B12 deficiency | Loss of vibration and proprioception; positive Romberg | Upper motor neuron pattern if myelopathy | May have combined pattern (absent ankle jerks, brisk knee jerks) | Pallor, glossitis, cognitive changes |
| Guillain-Barré syndrome | Distal paresthesias, often mild sensory signs | Ascending weakness, often severe | Areflexia or hyporeflexia | Facial weakness, respiratory compromise |
| Small fiber neuropathy | Pinprick and temperature affected; vibration and proprioception normal | Normal strength | Normal reflexes | Autonomic symptoms; allodynia may be present |
Important Teaching Point
A normal neurological examination does not exclude significant pathology. Early peripheral neuropathy, small fiber neuropathy, and even some radiculopathies may present with completely normal examination findings. The history — particularly the distribution pattern and temporal evolution of symptoms — often provides more localizing information than the examination in early or mild cases. Conversely, always take objective findings seriously, even if the patient’s symptoms seem out of proportion.
Spine Examination
- Inspection: Posture, scoliosis, kyphosis, surgical scars
- Palpation: Midline tenderness (vertebral pathology), paraspinal muscle spasm
- Range of motion: Cervical and lumbar flexion, extension, rotation; note if movement reproduces symptoms
- Percussion: Tenderness over spinous processes may indicate infection, fracture, or metastatic disease
5. Differential Diagnosis
Systematic approach organized by probability, duration, and anatomical localization
Acute Paresthesia (Duration: Less than 4 weeks)
| Probability | Condition | Key Features | Red Flags |
|---|---|---|---|
| COMMON (approximately 60%) | Nerve compression or entrapment | Positional symptoms, single nerve distribution, relieved by position change | Progressive weakness, muscle wasting |
| COMMON | Hyperventilation syndrome | Perioral and bilateral hand tingling, anxiety, lightheadedness, young patient | None (benign) |
| COMMON | Cervical or lumbar radiculopathy | Dermatomal distribution, neck or back pain, worse with movement or Valsalva | Progressive weakness, bowel/bladder dysfunction |
| LESS COMMON (approximately 25%) | Transient ischemic attack or stroke | Sudden onset, hemisensory distribution, associated weakness or speech changes | Any sudden-onset hemisensory symptoms require urgent evaluation |
| LESS COMMON | Herpes zoster (shingles) | Dermatomal pain and paresthesia, precedes rash by 2-3 days | Ophthalmic involvement, immunocompromised patient |
| LESS COMMON | Electrolyte disturbance | Hypocalcemia, hypomagnesemia, hypokalemia; perioral and acral distribution | Tetany, cardiac arrhythmias, altered mental status |
| UNCOMMON BUT SERIOUS (approximately 15%) | Guillain-Barré syndrome | Ascending paresthesias with progressive weakness, areflexia, recent infection | Rapidly progressive, respiratory involvement, autonomic instability |
| UNCOMMON BUT SERIOUS | Spinal cord compression | Sensory level, bilateral symptoms, bowel/bladder dysfunction | Any sensory level is a red flag requiring urgent imaging |
| UNCOMMON BUT SERIOUS | Transverse myelitis | Rapid onset sensory level, weakness below level, bladder dysfunction | Rapid progression, respiratory compromise if high cervical |
| UNCOMMON BUT SERIOUS | Multiple sclerosis (first presentation) | Young adult, partial sensory symptoms, may have prior vague episodes | Optic neuritis, internuclear ophthalmoplegia, Lhermitte’s sign |
Chronic Paresthesia (Duration: Greater than 3 months)
Step-by-Step Approach to Chronic Paresthesia:
- Step 1: Determine the distribution pattern — Is it length-dependent (stocking-glove), dermatomal, single nerve, or non-anatomical?
- Step 2: Identify obvious causes — Is the patient diabetic? Taking neurotoxic medications? History of alcohol abuse?
- Step 3: Check for the “treatable causes” — B12 deficiency, thyroid disease, diabetes, monoclonal gammopathy
- Step 4: Consider electrodiagnostic studies to characterize the neuropathy (axonal vs demyelinating, sensory vs sensorimotor)
- Step 5: If initial workup negative, consider less common causes or referral to neurology
| Probability | Condition | Approximate Frequency | Key Distinguishing Features |
|---|---|---|---|
| COMMON | Diabetic peripheral neuropathy | 30-35% of chronic cases | Symmetric stocking-glove, burning pain, known diabetes or prediabetes |
| COMMON | Idiopathic peripheral neuropathy | 25-30% of chronic cases | Older adults, symmetric sensory polyneuropathy, no identifiable cause after workup |
| COMMON | Carpal tunnel syndrome | 15-20% of chronic cases | Median nerve distribution, nocturnal symptoms, thenar wasting late |
| COMMON | Chronic cervical or lumbar radiculopathy | 10-15% of chronic cases | Dermatomal pattern, associated back or neck pain, provocative maneuvers positive |
| LESS COMMON | Alcoholic neuropathy | 5-10% | History of heavy alcohol use, often combined with nutritional deficiency |
| LESS COMMON | Vitamin B12 deficiency | 5-8% | Proprioceptive loss, sensory ataxia, may have upper motor neuron signs |
| LESS COMMON | Chemotherapy-induced neuropathy | 5-8% | Temporal relationship to treatment, dose-dependent, may persist after cessation |
| LESS COMMON | Small fiber neuropathy | 5-7% | Burning pain, normal nerve conduction studies, autonomic symptoms |
| LESS COMMON | Chronic inflammatory demyelinating polyneuropathy | 2-5% | Progressive or relapsing weakness, areflexia, elevated cerebrospinal fluid protein |
| UNCOMMON | Hereditary neuropathy (Charcot-Marie-Tooth) | 1-3% | Family history, pes cavus, hammer toes, slowly progressive since childhood |
| UNCOMMON | Paraproteinemic neuropathy | 1-3% | Monoclonal gammopathy on serum protein electrophoresis, older adults |
| UNCOMMON | Vasculitic neuropathy | Less than 2% | Mononeuritis multiplex pattern, systemic symptoms, elevated inflammatory markers |
| UNCOMMON | Paraneoplastic sensory neuronopathy | Less than 1% | Non-length-dependent, asymmetric, ataxia prominent, associated malignancy |
Anatomical Approach to Localization
Peripheral Nerve (Mononeuropathy)
Carpal tunnel syndrome (median nerve)
Cubital tunnel syndrome (ulnar nerve)
Meralgia paresthetica (lateral femoral cutaneous)
Peroneal neuropathy at fibular head
Tarsal tunnel syndrome (tibial nerve)
Nerve Root (Radiculopathy)
Cervical disc herniation (C5-C8)
Cervical spondylosis with foraminal stenosis
Lumbar disc herniation (L4-S1)
Lumbar spinal stenosis
Herpes zoster radiculitis
Polyneuropathy (Length-Dependent)
Diabetic peripheral neuropathy
Alcoholic neuropathy
Chemotherapy-induced neuropathy
Idiopathic axonal polyneuropathy
Uremic neuropathy
Hereditary neuropathies
Central Nervous System
Multiple sclerosis
Thalamic stroke
Cervical myelopathy
Transverse myelitis
Syringomyelia
B12 deficiency (subacute combined degeneration)
Drug-Induced Paresthesia and Neuropathy
| Drug or Drug Class | Mechanism | Characteristics | Time to Resolution After Stopping |
|---|---|---|---|
| Platinum compounds (cisplatin, oxaliplatin) | Dorsal root ganglion toxicity, mitochondrial dysfunction | Sensory predominant, may have acute cold-triggered symptoms (oxaliplatin) | Months to permanent; may worsen initially after stopping (“coasting”) |
| Taxanes (paclitaxel, docetaxel) | Microtubule disruption, axonal transport impairment | Stocking-glove sensory loss, dose-dependent | Months; partial recovery common |
| Vinca alkaloids (vincristine) | Microtubule disruption | Mixed sensorimotor, often dose-limiting | Months; may be incomplete |
| Metronidazole | Axonal degeneration (mechanism unclear) | Sensory predominant, may affect central nervous system | Weeks to months; usually reversible if caught early |
| Isoniazid | Pyridoxine (B6) depletion | Sensory polyneuropathy, preventable with B6 supplementation | Weeks to months with B6 supplementation |
| Nitrofurantoin | Axonal degeneration | Sensorimotor, more common with renal impairment and prolonged use | Months; may be permanent |
| Amiodarone | Lysosomal dysfunction, demyelination | Mixed sensorimotor, may be demyelinating | Months (long half-life); often incomplete recovery |
| Phenytoin (chronic use) | Axonal degeneration, folate depletion | Mild sensory neuropathy with very long-term use | Partial improvement over months |
| Statins | Uncertain; possibly mitochondrial | Rare; sensory predominant polyneuropathy | Weeks to months; usually resolves |
| Fluoroquinolones | Mitochondrial toxicity, oxidative stress | May be prolonged or permanent; associated with tendinopathy | Variable; may be prolonged |
| Pyridoxine (vitamin B6) excess | Sensory neuronopathy at high doses (more than 200 mg/day) | Pure sensory, non-length-dependent, ataxia | Months; may have permanent sequelae |
Mononeuritis Multiplex — A Pattern Requiring Investigation
When multiple individual nerves are affected asymmetrically and asynchronously, consider:
- Vasculitis: Polyarteritis nodosa, granulomatosis with polyangiitis, eosinophilic granulomatosis with polyangiitis
- Diabetes mellitus: Can cause multiple mononeuropathies
- Sarcoidosis: Multifocal nerve involvement
- Leprosy: In endemic areas; patchy sensory loss with skin lesions
- Hereditary neuropathy with liability to pressure palsies
- Multifocal motor neuropathy: Pure motor variant
This pattern often indicates a systemic process and warrants comprehensive investigation including inflammatory markers, vasculitis workup, and often nerve biopsy.
Quick Reference: “If You See This, Think This”
| Clinical Clue | Think This First | Next Step |
|---|---|---|
| Nocturnal hand tingling, shaking hand relieves it | Carpal tunnel syndrome | Nerve conduction studies; wrist splinting |
| Stocking-glove distribution in a diabetic | Diabetic peripheral neuropathy | Confirm glycemic control; screen for other causes |
| Dermatomal pain followed by vesicular rash | Herpes zoster | Start antiviral within 72 hours of rash |
| Ascending weakness with areflexia after viral illness | Guillain-Barré syndrome | Urgent hospitalization; monitor respiratory function |
| Sensory level on trunk examination | Spinal cord pathology | Urgent MRI spine; consider cord compression |
| Electric shock down spine with neck flexion | Cervical myelopathy or multiple sclerosis | MRI cervical spine and brain |
| Burning feet with normal reflexes and strength | Small fiber neuropathy | Skin biopsy; autonomic testing |
| Perioral and bilateral hand tingling with anxiety | Hyperventilation syndrome | Reassurance; check calcium if uncertain |
| Young woman with relapsing sensory symptoms | Multiple sclerosis | MRI brain and spine with contrast |
| Sensory ataxia with absent ankle jerks but brisk knee jerks | Vitamin B12 deficiency (subacute combined degeneration) | Check B12, methylmalonic acid; start replacement |
| Pes cavus and hammer toes with family history | Charcot-Marie-Tooth disease | Nerve conduction studies; genetic testing |
| Sudden hemisensory loss | Stroke (thalamic or cortical) | Emergency imaging; stroke protocol |
6. Diagnostic Investigations
A stepwise, cost-effective approach guided by clinical suspicion
Baseline Investigations for All Patients with Unexplained Paresthesia
| Investigation | Purpose | What to Look For | Practical Points |
|---|---|---|---|
| Fasting glucose and HbA1c | Screen for diabetes and prediabetes | Fasting glucose ≥7.0 mmol/L or HbA1c ≥6.5% indicates diabetes; HbA1c 5.7-6.4% indicates prediabetes | Prediabetes can cause neuropathy; oral glucose tolerance test more sensitive |
| Complete blood count | Screen for macrocytic anemia (B12/folate), infection | Elevated MCV suggests B12 or folate deficiency; may be normal even with deficiency | Anemia may be absent in neurological B12 deficiency |
| Vitamin B12 level | Identify treatable deficiency | Low B12 (less than 200 pg/mL) is diagnostic; 200-400 pg/mL is borderline | If borderline, check methylmalonic acid (elevated in true deficiency) |
| Thyroid-stimulating hormone | Screen for hypothyroidism | Elevated TSH indicates hypothyroidism | Hypothyroidism associated with carpal tunnel and polyneuropathy |
| Renal function (creatinine, eGFR) | Screen for uremic neuropathy | Chronic kidney disease stage 4-5 can cause uremic neuropathy | Also important for medication dosing considerations |
| Liver function tests | Screen for hepatic disease, alcohol-related | Elevated GGT suggests alcohol use; hepatic dysfunction may cause neuropathy | Chronic liver disease associated with various neuropathies |
| Serum protein electrophoresis with immunofixation | Screen for monoclonal gammopathy | Monoclonal spike indicates paraproteinemia | Found in 5-10% of idiopathic neuropathies; may require hematology referral |
| Erythrocyte sedimentation rate and C-reactive protein | Screen for inflammation, vasculitis | Elevated values suggest inflammatory or vasculitic process | If elevated with mononeuritis multiplex pattern, consider vasculitis workup |
Consider Adding to Baseline Panel Based on Clinical Context
- Folate level: If macrocytic anemia or dietary restriction
- HIV serology: If risk factors present or unexplained neuropathy
- Hemoglobin A1c alone may miss prediabetes: Consider oral glucose tolerance test in high-risk patients
- Vitamin B6 level: If taking supplements (toxicity) or isoniazid (deficiency)
Targeted Investigations by Suspected Etiology
If Suspecting Peripheral Polyneuropathy
First-Line Tests
- Nerve conduction studies and electromyography: Gold standard for characterizing neuropathy; distinguishes axonal from demyelinating, sensory from motor
- Baseline blood panel: As above (glucose, B12, TSH, SPEP)
Second-Line Tests
- Oral glucose tolerance test: If fasting glucose and HbA1c normal but diabetes suspected
- Methylmalonic acid and homocysteine: If B12 borderline (200-400 pg/mL)
- Anti-ganglioside antibodies: If demyelinating features or motor predominant
- Genetic testing: If hereditary neuropathy suspected (family history, pes cavus)
If Suspecting Small Fiber Neuropathy
First-Line Tests
- Nerve conduction studies: Typically normal (assesses large fibers only)
- Skin punch biopsy: Gold standard; measures intraepidermal nerve fiber density; reduced density confirms diagnosis
Second-Line Tests
- Quantitative sudomotor axon reflex test: Assesses autonomic small fiber function
- Autonomic function testing: Heart rate variability, tilt table test
- Screen for causes: Glucose tolerance test, Sjögren antibodies (SSA/SSB), celiac serology, amyloid workup
If Suspecting Carpal Tunnel Syndrome
First-Line Tests
- Nerve conduction studies: Prolonged distal sensory latency (greater than 3.5 ms) and motor latency (greater than 4.2 ms) across the wrist
- Clinical diagnosis may be sufficient: If classic presentation and positive provocative tests
Second-Line Tests
- Ultrasound of wrist: Cross-sectional area of median nerve greater than 10-12 mm² is abnormal
- MRI wrist: Rarely needed; for atypical cases or to exclude mass lesion
- Screen for associated conditions: Thyroid function, diabetes, rheumatoid arthritis
If Suspecting Radiculopathy
First-Line Tests
- MRI of relevant spine segment: Gold standard for visualizing disc herniation, foraminal stenosis, cord compression
- Plain radiographs: May show degenerative changes but cannot visualize soft tissue
Second-Line Tests
- Electromyography: Useful if MRI findings don’t correlate with symptoms; can confirm active denervation in specific myotome
- CT myelography: Alternative if MRI contraindicated
If Suspecting Multiple Sclerosis
First-Line Tests
- MRI brain with gadolinium: Look for periventricular, juxtacortical, and infratentorial white matter lesions
- MRI cervical and thoracic spine: Spinal cord lesions support diagnosis
Second-Line Tests
- Cerebrospinal fluid analysis: Oligoclonal bands (present in 85-90%), elevated IgG index
- Visual evoked potentials: Prolonged P100 latency suggests optic nerve demyelination
- Optical coherence tomography: Retinal nerve fiber layer thinning
If Suspecting Guillain-Barré Syndrome
Urgent Tests
- Lumbar puncture: Albuminocytologic dissociation (elevated protein, normal cell count); may be normal in first week
- Forced vital capacity: Monitor respiratory function; less than 20 mL/kg indicates impending respiratory failure
Additional Tests
- Nerve conduction studies: Demyelinating features (prolonged distal latencies, conduction block); may be normal early
- Anti-ganglioside antibodies: GQ1b antibodies in Miller Fisher variant
- MRI spine with contrast: Nerve root enhancement supports diagnosis
Understanding Nerve Conduction Studies and Electromyography
| Finding | Indicates | Examples |
|---|---|---|
| Reduced amplitude | Axonal loss (fewer functioning nerve fibers) | Diabetic neuropathy, toxic neuropathy, axonal Guillain-Barré |
| Slowed conduction velocity | Demyelination (impaired saltatory conduction) | Chronic inflammatory demyelinating polyneuropathy, hereditary demyelinating neuropathy |
| Prolonged distal latency | Distal demyelination or conduction slowing | Carpal tunnel syndrome, demyelinating neuropathy |
| Conduction block | Focal demyelination preventing impulse transmission | Multifocal motor neuropathy, acute inflammatory demyelinating polyneuropathy |
| Fibrillation potentials on EMG | Active denervation (muscle fiber spontaneous activity) | Radiculopathy, motor neuron disease, severe neuropathy |
| Chronic neurogenic changes on EMG | Reinnervation after prior denervation | Chronic radiculopathy, old polio, chronic neuropathy |
Practical Points About Electrodiagnostic Studies
- Timing matters: Nerve conduction changes may take 1-2 weeks to develop after acute nerve injury; EMG changes take 2-3 weeks
- Normal studies don’t exclude neuropathy: Small fiber neuropathy and very early large fiber neuropathy may have normal studies
- Clinical correlation essential: Electrodiagnostic findings must be interpreted in clinical context
- Can localize: Helps distinguish radiculopathy from plexopathy from mononeuropathy
When to Order Imaging
| Clinical Scenario | Imaging Modality | What to Look For |
|---|---|---|
| Dermatomal symptoms with radicular pain | MRI of relevant spine segment | Disc herniation, foraminal stenosis, nerve root compression |
| Sensory level on examination | Urgent MRI entire spine | Cord compression, transverse myelitis, tumor, epidural abscess |
| Suspected multiple sclerosis | MRI brain and spine with gadolinium | Demyelinating lesions, dissemination in space and time |
| Sudden hemisensory symptoms | CT head (immediate) then MRI brain | Stroke (thalamic, cortical), hemorrhage |
| Suspected brachial or lumbosacral plexopathy | MRI of plexus | Tumor infiltration, inflammatory changes, structural abnormality |
| Atypical entrapment or mass suspected | Ultrasound or MRI of affected nerve | Nerve enlargement, mass lesion, anatomical variant |
Empiric Treatment Trials as Diagnostic Tools
When Diagnosis Remains Uncertain
In some cases, response to empiric treatment can support a suspected diagnosis:
- Vitamin B12 replacement: If borderline B12 level with consistent symptoms, treat with B12 and reassess. Clinical improvement supports the diagnosis.
- Wrist splinting for suspected carpal tunnel: Symptom improvement with nocturnal wrist splints supports the diagnosis of carpal tunnel syndrome.
- Trial of neuropathic pain medication: Does not confirm diagnosis but may improve quality of life while workup continues.
- Physical therapy for suspected radiculopathy: Improvement with specific exercises supports mechanical cause.
Stepwise Investigation Algorithm
Approach to Investigation Based on Clinical Presentation:
- All patients: Baseline blood panel (glucose, HbA1c, B12, TSH, renal function, SPEP, inflammatory markers)
- If length-dependent pattern: Proceed to nerve conduction studies if cause not identified on bloods
- If dermatomal pattern: MRI of relevant spine segment
- If mononeuropathy suspected: Nerve conduction studies to localize; ultrasound if mass suspected
- If central lesion suspected: MRI brain and/or spine depending on localization
- If normal nerve conduction studies but symptoms persist: Consider skin biopsy for small fiber neuropathy
- If mononeuritis multiplex pattern: Vasculitis workup; consider nerve biopsy
Less Common but Important Investigations
| Investigation | When to Order | What It Detects |
|---|---|---|
| Lumbar puncture | Suspected Guillain-Barré, chronic inflammatory demyelinating polyneuropathy, multiple sclerosis, infectious cause | Elevated protein (inflammatory neuropathies), oligoclonal bands (multiple sclerosis), cells (infection) |
| Nerve biopsy (sural nerve) | Suspected vasculitis, amyloidosis, sarcoidosis, leprosy; when diagnosis unclear after extensive workup | Vasculitic changes, amyloid deposits, granulomas, inflammatory infiltrates |
| Skin biopsy for nerve fiber density | Suspected small fiber neuropathy with normal nerve conduction studies | Reduced intraepidermal nerve fiber density confirms small fiber neuropathy |
| Genetic testing | Suspected hereditary neuropathy (family history, pes cavus, young onset) | Charcot-Marie-Tooth mutations, hereditary sensory neuropathies, familial amyloidosis |
| Paraneoplastic antibody panel | Non-length-dependent sensory neuropathy, rapid onset, asymmetric, known or suspected malignancy | Anti-Hu, anti-CV2/CRMP5, anti-amphiphysin (associated with small cell lung cancer, others) |
| Fat pad biopsy or genetic testing for TTR | Suspected amyloidosis (autonomic features, cardiomyopathy, family history) | Amyloid deposits; transthyretin mutations in hereditary amyloidosis |
7. Pattern Recognition and Clinical Decision-Making
Practical algorithms and decision pathways for paresthesia
Step 1: Is This Urgent?
| Clinical Scenario | Urgency Level | Immediate Action |
|---|---|---|
| Acute ascending weakness with paresthesias | EMERGENT | Hospitalize immediately; monitor respiratory function (forced vital capacity every 4 hours); consider Guillain-Barré syndrome |
| Sensory level on trunk with weakness or bladder symptoms | EMERGENT | Urgent MRI entire spine; neurosurgical consultation for possible cord compression |
| Sudden hemisensory loss (with or without weakness) | EMERGENT | Activate stroke protocol; immediate CT head; consider thrombolysis if within window |
| Paresthesias with fever and neck stiffness | EMERGENT | Evaluate for meningitis; lumbar puncture after CT if no contraindication; empiric antibiotics |
| Progressive weakness over days to weeks | URGENT | Neurology referral within days; nerve conduction studies; consider inflammatory neuropathy |
| New radicular symptoms with significant motor deficit | URGENT | MRI spine within 1-2 weeks; surgical referral if progressive weakness or severe deficit |
| Dermatomal pain preceding vesicular rash | URGENT | Start antiviral therapy within 72 hours of rash onset for best efficacy |
| Chronic stable sensory symptoms without weakness | ROUTINE | Outpatient workup; baseline blood tests; nerve conduction studies if indicated |
| Intermittent positional symptoms in single nerve distribution | ROUTINE | Trial of conservative measures (splinting, position modification); elective nerve conduction studies |
Step 2: Classify by Duration and Pattern
Acute (Less than 4 weeks)
Key Questions:
- Is there associated weakness?
- Is it progressing rapidly?
- Is there a sensory level?
Proceed to Algorithm A
Subacute (4 weeks to 3 months)
Key Questions:
- Is it progressive or stable?
- Any new medications?
- Nutritional risk factors?
Proceed to Algorithm B
Chronic (Greater than 3 months)
Key Questions:
- What is the distribution?
- Known diabetes or risk factors?
- Family history of neuropathy?
Proceed to Algorithm C
Step 3: Follow the Appropriate Algorithm
Algorithm A: Acute Paresthesia
| Clinical Scenario | Most Likely Diagnosis | Action |
|---|---|---|
| Ascending tingling and weakness following viral illness; areflexia | Guillain-Barré syndrome | Hospitalize; lumbar puncture; nerve conduction studies; monitor respiratory function |
| Sudden hemisensory symptoms; face involved | Stroke (thalamic or cortical) | Emergency CT/MRI; stroke protocol; neurology consultation |
| Sensory level on trunk; bilateral leg symptoms | Spinal cord pathology | Urgent MRI spine; if compression, emergent neurosurgical consultation |
| Dermatomal distribution with severe pain; immunocompetent | Herpes zoster (pre-rash or early) | Examine for vesicles; start antiviral if rash appears; analgesia |
| Perioral and bilateral hand tingling; anxious; hyperventilating | Hyperventilation syndrome | Reassurance; breathing retraining; check calcium if uncertain |
| Single nerve distribution; positional; relieved by movement | Transient nerve compression | Reassurance; avoid provocative positions; observe for recurrence |
| Arm symptoms with neck pain; dermatomal; Spurling positive | Cervical radiculopathy | Conservative management initially; MRI if red flags or no improvement in 4-6 weeks |
Algorithm B: Subacute Paresthesia
| Clinical Scenario | Most Likely Diagnosis | Action |
|---|---|---|
| Symmetric stocking-glove; new diabetes diagnosis or prediabetes | Early diabetic neuropathy | Optimize glycemic control; baseline nerve conduction studies; symptomatic treatment |
| Symmetric sensory loss with ataxia; vegan diet or malabsorption | Vitamin B12 deficiency | Check B12 and methylmalonic acid; start replacement; MRI spine if myelopathy suspected |
| Progressive symptoms following chemotherapy | Chemotherapy-induced neuropathy | Document severity; discuss with oncology about dose modification; symptomatic treatment |
| Young adult; relapsing symptoms; possible prior episode | Multiple sclerosis | MRI brain and spine with gadolinium; neurology referral |
| Progressive weakness and sensory symptoms; relapsing course | Chronic inflammatory demyelinating polyneuropathy | Nerve conduction studies (demyelinating features); lumbar puncture; neurology referral |
| Symptoms began after starting new medication | Drug-induced neuropathy | Review medication list; consider stopping culprit drug if safe; reassess in 4-8 weeks |
Algorithm C: Chronic Paresthesia
| Clinical Scenario | Most Likely Diagnosis | Action |
|---|---|---|
| Stocking-glove distribution; diabetic; reduced ankle reflexes | Diabetic peripheral neuropathy | Confirm with nerve conduction studies; optimize glucose; foot care; symptomatic treatment |
| Stocking-glove distribution; no identifiable cause after workup | Idiopathic peripheral neuropathy | Exclude treatable causes; symptomatic management; annual monitoring |
| Nocturnal hand symptoms; positive Phalen and Tinel | Carpal tunnel syndrome | Nerve conduction studies to confirm and grade; splinting; consider surgery if severe |
| Burning feet; normal reflexes and strength; normal nerve conduction studies | Small fiber neuropathy | Skin biopsy for nerve fiber density; autonomic testing; search for underlying cause |
| Pes cavus; hammer toes; family history of neuropathy | Charcot-Marie-Tooth disease | Nerve conduction studies (often demyelinating); genetic testing; genetic counseling |
| Older adult; monoclonal protein on serum protein electrophoresis | Paraproteinemic neuropathy | Hematology referral; further workup for myeloma or other plasma cell dyscrasia |
| Asymmetric multiple nerve involvement; elevated inflammatory markers | Vasculitic neuropathy | Vasculitis workup; consider nerve biopsy; rheumatology referral |
Pattern-Based Decision Framework
| Distribution Pattern | Localization | Key Investigations | Common Diagnoses |
|---|---|---|---|
| Stocking-glove (symmetric, length-dependent) | Peripheral polyneuropathy | Baseline bloods, nerve conduction studies | Diabetic, idiopathic, alcoholic, toxic neuropathy |
| Dermatomal (follows nerve root) | Radiculopathy | MRI spine | Disc herniation, foraminal stenosis, herpes zoster |
| Single peripheral nerve | Mononeuropathy | Nerve conduction studies, ultrasound | Carpal tunnel, ulnar neuropathy, meralgia paresthetica |
| Multiple individual nerves (asymmetric) | Mononeuritis multiplex | Vasculitis workup, nerve biopsy | Vasculitis, diabetes, sarcoidosis |
| Hemisensory (one side of body) | Central (thalamus or cortex) | MRI brain | Stroke, multiple sclerosis, tumor |
| Sensory level (all below a spinal level) | Spinal cord | Urgent MRI spine | Compression, myelitis, multiple sclerosis |
| Non-anatomical (doesn’t fit patterns) | Functional or systemic | Clinical assessment; exclude organic causes | Functional neurological disorder, hyperventilation, anxiety |
“What Do I Do If…” Decision Reference
| Clinical Situation | Immediate Action | Next Step |
|---|---|---|
| Patient has acute paresthesias and forced vital capacity is falling | Transfer to intensive care unit; prepare for intubation | Start intravenous immunoglobulin or plasmapheresis for Guillain-Barré syndrome |
| Patient has sensory level and urinary retention | Urgent MRI spine; catheterize bladder | Neurosurgical consultation if compression; high-dose steroids if transverse myelitis |
| Baseline workup is completely normal but symptoms persist | Obtain nerve conduction studies | If normal, consider skin biopsy for small fiber neuropathy |
| Nerve conduction studies show demyelinating pattern | Check for acquired causes (paraprotein, diabetes) | Consider chronic inflammatory demyelinating polyneuropathy if progressive; neurology referral |
| Patient is on chemotherapy and develops new neuropathy | Document severity using standardized grading | Discuss with oncology; consider dose reduction or agent change |
| B12 is borderline (200-400 pg/mL) with suspicious symptoms | Check methylmalonic acid (elevated if true deficiency) | Treat with B12 replacement if methylmalonic acid elevated or high clinical suspicion |
| Patient has carpal tunnel symptoms but wants to avoid surgery | Trial of nocturnal wrist splinting for 6-8 weeks | If no improvement, consider corticosteroid injection; surgery if severe or progressive |
| Young patient with relapsing-remitting sensory symptoms | Detailed neurological history for prior episodes | MRI brain and spine with contrast; refer to neurology if multiple sclerosis suspected |
Troubleshooting Refractory or Unexplained Paresthesia
When Standard Workup Is Negative, Ask These Questions
- Was the workup complete? Did it include serum protein electrophoresis, B12 with methylmalonic acid, glucose tolerance test?
- Were nerve conduction studies performed and interpreted by a specialist? Subtle abnormalities may be missed.
- Could this be small fiber neuropathy? Nerve conduction studies are normal; skin biopsy is required for diagnosis.
- Is the pattern truly anatomical? Non-anatomical patterns suggest functional neurological disorder or systemic cause.
- Are there autonomic symptoms? These may point to small fiber neuropathy or specific conditions (amyloidosis, diabetes).
- Is there a family history that was not initially disclosed? Hereditary neuropathies may be undiagnosed in family members.
- Has a less common cause been considered? Celiac disease, Sjögren syndrome, sarcoidosis, paraneoplastic syndrome.
- Would the patient benefit from neurology referral? Complex or unexplained cases may warrant specialist evaluation.
When to Refer to Neurology
Urgent Referral
- Rapidly progressive weakness
- Suspected Guillain-Barré syndrome
- Suspected spinal cord pathology
- Acute onset suggesting stroke
- Suspected multiple sclerosis (first presentation)
Routine Referral
- Unexplained neuropathy after baseline workup
- Atypical patterns (mononeuritis multiplex, non-length-dependent)
- Suspected hereditary neuropathy
- Progressive symptoms despite treatment
- Need for nerve conduction studies interpretation
- Consideration of nerve biopsy
8. Clinical Pearls and Pitfalls
Practical wisdom — learn from successes and avoid common mistakes
Must-Know Clinical Pearls
Distribution is everything: The pattern of sensory symptoms is the most valuable localizing information. A careful sensory map often points directly to the diagnosis before any tests are ordered.
Diabetes and prediabetes are the most common treatable causes: Always check fasting glucose and HbA1c. Consider oral glucose tolerance test if these are normal but suspicion remains high — prediabetes can cause neuropathy.
Normal nerve conduction studies do not exclude neuropathy: Small fiber neuropathy affects unmyelinated and small myelinated fibers that are not assessed by standard nerve conduction studies. Skin biopsy is required for diagnosis.
B12 deficiency can cause neurological damage before anemia develops: Do not wait for macrocytic anemia. Check B12 in all patients with unexplained neuropathy, and check methylmalonic acid if the B12 level is borderline.
Carpal tunnel syndrome is clinical: Classic nocturnal symptoms with hand shaking for relief (the “flick sign”) are highly suggestive. Nerve conduction studies confirm and grade severity but are not always required before treatment.
Always examine the feet in diabetic patients: Many patients with diabetic neuropathy are asymptomatic but have objective sensory loss on examination. Annual foot examinations prevent ulcers and amputations.
Serum protein electrophoresis should be part of the standard workup: Paraproteinemic neuropathy is found in 5-10% of patients with “idiopathic” neuropathy and may have treatment implications.
Lhermitte’s sign is a high-value clinical finding: Electric shock sensation with neck flexion strongly suggests cervical cord pathology. In a young patient, think multiple sclerosis; in an older patient, think cervical spondylotic myelopathy.
Critical Pitfalls to Avoid
Missing Guillain-Barré syndrome: Early symptoms may be dismissed as minor. Any patient with ascending paresthesias and progressive weakness needs urgent evaluation. Respiratory failure can develop rapidly — monitor forced vital capacity.
Ignoring a sensory level: A sensory level on examination indicates spinal cord pathology until proven otherwise. This requires urgent MRI — do not delay for outpatient workup.
Attributing hemisensory symptoms to anxiety: Sudden onset hemisensory symptoms are stroke until proven otherwise, even if the patient is young or anxious. Always image the brain.
Forgetting to ask about medications: Many common medications cause neuropathy. Always review the medication list, especially chemotherapy, antimicrobials (metronidazole, nitrofurantoin), and amiodarone.
Assuming normal nerve conduction studies exclude all neuropathy: Small fiber neuropathy causes significant symptoms but normal electrodiagnostic studies. If clinical suspicion is high, pursue skin biopsy.
Overlooking B6 toxicity: Patients taking high-dose pyridoxine (vitamin B6) supplements can develop sensory neuronopathy. Ask specifically about over-the-counter supplements.
Delaying antiviral therapy in herpes zoster: Antivirals are most effective when started within 72 hours of rash onset. Dermatomal pain with characteristic rash should prompt immediate treatment.
Labeling unexplained symptoms as “functional” without adequate workup: Complete the standard evaluation before considering functional neurological disorder. Some conditions (small fiber neuropathy, early multiple sclerosis) are easily missed.
Key Takeaways
- The distribution pattern of paresthesia is the single most important clue to localization — always map the sensory symptoms carefully.
- Red flags requiring urgent evaluation include: ascending weakness, sensory level, sudden hemisensory symptoms, bowel or bladder dysfunction, and rapidly progressive symptoms.
- Diabetes and prediabetes are the most common identifiable causes of peripheral neuropathy in developed countries — always screen for glucose abnormalities.
- A basic workup for unexplained paresthesia should include: fasting glucose, HbA1c, vitamin B12, thyroid-stimulating hormone, renal function, and serum protein electrophoresis.
- Normal nerve conduction studies do not exclude neuropathy — small fiber neuropathy requires skin biopsy for diagnosis.
- Carpal tunnel syndrome is primarily a clinical diagnosis — classic nocturnal symptoms with the “flick sign” are highly specific.
- Guillain-Barré syndrome can progress to respiratory failure within days — any patient with ascending weakness and paresthesias needs hospitalization and respiratory monitoring.
- A sensory level on examination indicates spinal cord pathology and requires urgent MRI of the spine.
- Many medications cause neuropathy — always review the medication list, especially in patients with subacute onset symptoms.
- When standard workup is negative, consider less common causes: small fiber neuropathy, celiac disease, Sjögren syndrome, sarcoidosis, and hereditary neuropathies.
Quick Reference Algorithm
Systematic Approach to Paresthesia:
- Assess urgency: Look for red flags (weakness, sensory level, rapid progression, bowel/bladder symptoms). If present, act immediately.
- Map the distribution: Is it length-dependent, dermatomal, single nerve, hemisensory, or non-anatomical? This determines the localization.
- Characterize the timeline: Acute, subacute, or chronic? Progressive, stable, or relapsing? This narrows the differential.
- Take a thorough history: Use the TINGLE mnemonic. Ask about medications, alcohol, diet, occupation, and family history.
- Perform a focused examination: Sensory testing (all modalities), motor examination, reflexes, and special tests appropriate to the suspected localization.
- Order baseline investigations: Glucose, HbA1c, B12, TSH, renal function, serum protein electrophoresis for all unexplained cases.
- Obtain targeted investigations: Nerve conduction studies for peripheral neuropathy, MRI for radiculopathy or central lesions, skin biopsy for suspected small fiber neuropathy.
- Treat the underlying cause: Optimize glucose control, replace B12, stop offending medications, decompress entrapped nerves.
- Manage symptoms: Neuropathic pain medications (gabapentinoids, duloxetine, tricyclic antidepressants) for symptomatic relief while addressing the cause.
- Refer to neurology: When the diagnosis is unclear, symptoms are progressive despite treatment, or specialized testing (nerve biopsy, genetic testing) is needed.